Medchemexpress LLC HFY-4A | 2094810-82-7 | 99.3% | 333.38 | C20H19N3O2 | 10 MG

Supplier:  Medchemexpress LLC HY14963110MG

HFY-4A is a histone deacetylase (HDAC) inhibitor used as a research reagent in preclinical cancer studies. It inhibits breast cancer cell proliferation, migration, and invasion, induces apoptosis and immunogenic cell death, and has shown tumor growth inhibition in breast cancer xenograft models. The compound is supplied as a solid, white to off-white powder with high purity and is soluble in DMSO.

• Histone deacetylase (HDAC) inhibitor for preclinical research.
• Inhibits breast cancer cell proliferation, migration, and invasion.
• Induces apoptosis and immunogenic cell death in cancer cells.
• Demonstrated tumor growth inhibition in xenograft models.
• High purity (99.34%) suitable for biochemical and cell-based assays.
• Soluble in DMSO (125 mg/mL), enabling stock solution preparation.
• Stable as powder when stored at -20°C for long-term storage.

Catalog No. 50-002-86815